Patents by Inventor Daniel MARCKART

Daniel MARCKART has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAL USE OF COMPOUND III
    Publication number: 20210130362
    Abstract: The present invention relates to compound III and its use for treatment and/or prevention of diseases of the schizophrenia spectrum and other psychotic disorders, first episodes of these diseases such as first episode of psychosis (FEP), relapses of these diseases such as reduction of relapse in patients with schizophrenia (REX). The invention also relates to polymorphs of compound III, and pharmaceutical compositions comprising compound III and/or its polymorphs.
    Type: Application
    Filed: January 11, 2021
    Publication date: May 6, 2021
    Inventors: Michael Steven SAND, Holger ROSENBROCK, Riccardo GIOVANNINI, Masashi ADACHI, Bodo BETZEMEIER, Tobias BRODMANN, Takayuki KAMATA, Yohei KAWABATA, Masanori ITO, Daniel MARCKART, Manabu NAKATANI, Ulrike WERTHMANN
  • Medical use of compound III
    Patent number: 10919898
    Abstract: The present invention relates to compound III and its use for treatment and/or prevention of diseases of the schizophrenia spectrum and other psychotic disorders, first episodes of these diseases such as first episode of psychosis (FEP), relapses of these diseases such as reduction of relapse in patients with schizophrenia (REX). The invention also relates to polymorphs of compound III, and pharmaceutical compositions comprising compound III and/or its polymorphs.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: February 16, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Michael Steven Sand, Holger Rosenbrock, Riccardo Giovannini, Masashi Adachi, Bodo Betzemeier, Tobias Brodmann, Takayuki Kamata, Yohei Kawabata, Masanori Ito, Daniel Marckart, Manabu Nakatani, Ulrike Werthmann
  • Medical Use of Compound III
    Publication number: 20180237445
    Abstract: The present invention relates to compound III and its use for treatment and/or prevention of diseases of the schizophrenia spectrum and other psychotic disorders, first episodes of these diseases such as first episode of psychosis (FEP), relapses of these diseases such as reduction of relapse in patients with schizophrenia (REX). The invention also relates to polymorphs of compound III, and pharmaceutical compositions comprising compound III and/or its polymorphs.
    Type: Application
    Filed: February 21, 2018
    Publication date: August 23, 2018
    Inventors: Michael Steven SAND, Holger ROSENBROCK, Riccardo GIOVANNINI, Masashi ADACHI, Bodo BETZEMEIER, Tobias BRODMANN, Takayuki KAMATA, Yohei KAWABATA, Masanori ITO, Daniel MARCKART, Manabu NAKATANI, Ulrike WERTHMANN